Fort Lee, NJ -- (SBWIRE) -- 11/30/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne, and other health and wellness concerns, announced today that its 2017 Black Friday and Cyber Monday e commerce sales for its leading dermatological product, AcnEase, grew 115% over the same sales event in 2016.

The social media campaigns associated with Black Friday and Cyber Monday more than doubled sales in the USA and Canada. Additionally, Herborium websites experienced a substantial increase in international traffic from first official Black Friday in France and the second one in Great Britain. The Hut Group LLC, Herborium's UK distributor launched its first Black Friday/Cyber Monday promotional campaign which the Company expects to result in increased wholesale orders.

Herborium's AcnEase® product has a track record for repeat sales of over 55% for up to 3 months following an initial order and over 35% for 4 and more months following an initial order. The Company anticipates this combined with the sales growth from Black Friday/Cyber Monday to increase the number of new customers and therefore continued sales appreciation going forward. Furthermore, this growth is expected to augment product brand recognition and future new customer acquisition as well.

The Company has also seen an increase in interest and demand for the Rejuvel 3D Skin Renewal Cream for acne scars. Herborium has been test marketing the Rejuvel product as an add-on to its signature product (https://www.acnease.com/products/rejuvel-3d.htm). As a result of the positive test marketing, the Company has launched an international marketing campaign and begun full distribution of the product throughout its network.

The Company will continue its marketing push throughout the holiday season by adding a special series of events targeting the rapidly growing markets for AcnEase in Europe, Australia and Latin America.

To date Herborium's 2017 sales performance surpassed 2016 sales by 16.5%, confirming management's expectations for record 2017 sales results.

Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium Group, stated, "We expect a continued increase of sales through the end of the 4th quarter of 2017 and into 2018 given the new initiatives that have been put in place."  Dr. Agnes P. Olszewski, continued "The Company's growth in the USA and abroad continues and Herborium will announce shortly new sales initiatives for 2018 to further support this growth.  We look forward to the very strong ending of 2017, and a very successful 2018"

Over 75 million people have acne in the USA. Seventy five percent of all individuals will suffer from acne at some point in their lives.  The acne treatment and prevention market is growing while at the same time no new products are emerging and the number of previously used treatments is dwindling or restricted because of recognized health concerns. (Accutane, antibiotics, oral contraceptives as examples) The average age of the acne sufferer has increased during the past decade from 21 years old to 26 years old, making adult acne an epidemic.

AcnEase® is a systemic, proprietary all herbal product that contains no chemicals and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts with no adverse side effects. From a regulatory perspective, AcnEase is considered a nutraceutical allowing AcnEase to take advantage of the rapid global growth of the nutraceutical market.  For instance, the global nutraceutical market is valued at around USD 250 billion in 2016 and is expected to reach around USD 385 billion by 2021, at a CAGR of 7.5% from 2016 to 2021. US nutraceutical market has dominated this growth accounting for ~ 36% of this growth.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics®  company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).  The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage.  Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com,  www.acnease.fr and www.acneasesp.com.

Safe Harbor Statement 
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties.  The Company's actual future results could materially differ from those discussed.   The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com 
DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 10/26/2017 -- Herborium Group, Inc. (OTCMKTS:HBRM), a Botanical Therapeutics Company and the provider of unique all botanical medicinal products (Botanical Therapeutics) that target dermatological issues such as acne, and other health and wellness concerns, announced today its results for the 9 month period ending August 30, 2017. For the 9 month period the Company achieved revenue growth of 8% to $672,000, and gross margins increase 8.9% to $412,000.  Additionally, the Company has maintained a 61% gross profit margin. This marks the consecutive 16th quarter of continued growth.

The Company's continued success to date is a direct result of the initiatives and execution of numerous efforts to improve the marketing strategy, increase distribution and a growing international social media presence.

In the first quarter of 2017 the Company entered the $1.4 trillion Hispanic market which continues to grow at a rate over 3 times higher than that the of the total U.S. market. This expansion has been coupled with an increase in our current distributor relationships resulting in expansion throughout the French market and an affiliation with a Super Seller distributor on Amazon.

A commitment to our social media presence and marketing has resulted in ourAcnEase US Facebook surpassing 100,000 likes and AcnEase France Facebook exceeding 80,000 likes. Our initial expansion in the Hispanic market has already seen AcnEase Spanish Facebook grow over 6000% to date. The Company is also proud to announce that its AcnEase Blog has been ranked No 1 in the acne skincare blog on Internet for the 3rd consecutive year (2015, 2016, 2017.)

The actions through the 3rd quarter have also positioned the Company to commence monetizing Herborium's other Botanical Therapeutics that are ready for market, including our unique Women and Men's Sexual Formulas.

Outlook for the Fourth Quarter of 2017:

Herborium is committed to marketing, distribution and new product launches to further the growth of its business, sales and product awareness in the US and abroad through tothe end of 2017 and beyond.

The Company continues its efforts to increase market penetration and sales for AcnEase in both retail and wholesale sectors. During the last quarter of 2017 Herborium is focusing on new valuable partnerships to maximize Herborium and Herborium's products, media exposure and increasing the Company's brand (corporate and product) equity that will lead to further sales growth and enhanced shareholder value.Specifically, we are looking to new products that provide advantageous co-marketing opportunities and platforms such as our first co-marketed product for acne scars and marks -Rejuvel.  Rejuvel has already been launched and generates revenues.  Additionally, we recently announced a distribution relationship with UrthMarket (www.urthmarket.com), the biggest GMO-Free healthy marketplace online. UrthMarket is committed to GMO-free, organic and all-natural products only and is currently the leading healthy and GMO-Free monthly snack food subscription service with hundred thousands of members worldwide. Unlike other marketplaces that charge consumers anywhere from $59 - $140 a year in store access fees, UrthMarket has zero monthly or yearly memberships fees.  Consumers are set to save millions of dollars a year, with free access to search, discover, share and purchase from the largest selection of healthy and GMO-free products available online including snacks, foods, beverages, supplements, personal care products and other goods. Herborium expects a very profitable relationship with UrthMarket due to the high synergy between both companies target markets.

In closing, the last quarter of 2017 is also dedicated to establishing solid avenues to monetize our proprietary sexual Botanical Therapeutic Formulas and add new products to our dermatological product line. Herborium expects to add at least one more product to its product portfolio going into2018.

Acnease

AcnEase is free of chemicals, hormones, preservatives, gluten, dairy, sugar and GMOs.Named a top beauty pick by Cosmopolitan France in May 2016, AcnEase provides not only a breakthrough treatment for different types of acne but also award winning content (AcnEase Blog is a Winner of the Best Skincare Blog by Healthline for 3 consecutive years) focused on results-driven, life-changing information such as cutting edge educational data on acne, its treatment options, safety related issues, social impact of acne, and tips on coping with every day and special situation skincare problems.

About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, womens health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr, www.acneasesp.com, www.acnease.co.uk.

Safe Harbor Statement
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed.  The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 08/16/2017 -- Herborium Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) announced today that it has started the roll-out of the new products by launching the topical acne scar product (www.acnease.com). This introduction of a plant cells and antigravity technology based product, Rejuvel 3D, allows Herborium to use its brand equity and increase revenues with a nominal increase of the marketing and fulfillment cost. The carefully selected addition to AcnEase Regimens speeds up collagen production and skin turnover helping to reduce acne scars, to eliminate acne marks and spots while moisturizing and rejuvenating the skin. This unique combination of benefits allows Herborium to enter into the global facial rejuvenation market that is estimated to expand from a value of US$18 Bn in 2014 to a value of US$26.5 Bn by 2021. The acne scars treatment market is expected to be worth $34.5 Billion by 2025 | Growth Rate: 9.7%. In addition as people age, acne scars often become more noticeable because our skin loses collagen so the age defying market and acne scar treatment market partially overlap allowing for more economic use of our resources. The introduction of this product will be the first of many planned collaborations with other product manufacturers to bring their products to market through our extensive distribution channels.

In addition to the new dermatological product launch, Herborium is preparing a roll-out of two new products under its Sexual Health & Performance Series. The initial products in the series are Lasting Pleasure for Her and Lasting Power for Him with a combined market worth over $10 Billion by 2019.

Lasting Pleasure®, a proprietary, innovative product that increases women's libido, combats the signs of sexual frigidity and fosters receptiveness and the capacity to experience more intensive orgasms. Lasting Pleasure® improves women's sexual satisfaction and unlike topical products and other aphrodisiacs can be used long term to improve and preserve sexual performance for years.  The Product has also proven utility in addressing female sexual problems resulting from the use of specific medications (anti-depressants) or hysterectomy and therefore represents a unique product entry into the growing market of female sexual health needs.

Lasting Power® focuses on improving sexual stamina and enhancing libido, staying power and endurance in men.

Lasting Pleasure® and Lasting Power® are unique, all herbal scientifically developed complex herbal formulas are safe and efficacious alternatives to commonly-prescribed erectile dysfunction (ED) medications or other sexual enhancers. One-of-a-kind Sexual Botanical Therapeutic® for Women allows for both partners to improve their satisfaction in a healthy yet dramatic way.

The Company has manufactured an initial 10,000 units of each product as starting inventory to begin its market launch of the Sexual Health & Performance Series. The early stages of our market launch will be directed towards developing proper partnerships with an extensive customer base in the sexual health and performance market such as the platform we have developed in the acne and beauty space.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and ecommerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com.

Safe Harbor Statement
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Talks with Two Potential MLM Partners in Progress and October MLM Las Vegas Conference Participation Planned

Fort Lee, NJ -- (ReleaseWire) -- 07/12/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and acne scars, and other health and wellness concerns including women and men sexual health and energy deficiency has announced today that the company is planning to enter Multi Level Marketing Space also known as referral marketing and is presently in talks with two potential partners in this space. One potential partner is interested to market Herborium AcnEase Skin Management System while another well established national MLM company would focus on Herborium's Sexual Botanical Therapeutics. We will keep our shareholders abreast with the progress of this initiative.

According to Direct Selling Association, an industry group 2016 multi-level marketing distributors generated sales of $36 billion in the USA alone. Worldwide Muti-Level Marketing grossed $160 billion.

What creates an additional opportunity for Herborium products is the fact that wellness products are the highest grossing products among MLM products category and account for close to 15 % of all sales. Wellness products are also the fastest growing segment of the MLM market in the US and worldwide.

In addition to the on-going talks, Herborium plans to attend the Annual MLM Conference in Las Vegas October 26 and 27, 2017 to scope the space and generate additional leads and opportunities.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products(FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com.

Safe Harbor Statement: 
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email Investors Relations: @Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 06/29/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and acne scars, and other health and wellness concerns including women and men sexual health and energy deficiency has announced today that the company is currently pursuing engagement with potential interested partners that will provide access to Asian markets for Herborium Botanical Therapeutics® while extending the Company's US natural and organic health and wellness product portfolio through additional product offering and manufacturing capabilities. The contemplated business combination has a significant value to the Company providing for a potential for multi-million dollar revenues within next 12-24 months. We will inform investors about the progress of this initiative and wherever LOI is crafted.

The Asian market is assessed to have over 200 million acne sufferers. The total global market for acne treatment is over $4 billion a year, with the spending on skin conditions growing at a rate of over 11 percent per year. Due to environmental conditions and social demand, more and more individuals seek specialty treatment of acne and related skin conditions.

Asian market for natural sexual enhancement products dominates the space with over 70% of the $1.5 Billion of a natural sexual products market being generated in Asia. Herborium Lasting Pleasure formula for women and Lasting Power formula for men are an perfect fit for this demand.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com,  www.acnease.fr and www.acneassp.com.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 06/27/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and acne scars, and other health and wellness concerns including women and men sexual health and energy deficiency is currently engaged in the serious pursuit of new partners that will provide significant value to the Company. From co-marketing to licensing, from distribution to business combination Herborium has been involved in talks with potential partners from Canada Europe ad Asia. Specific announcements on these issues will follow soon.

Revenues & Sales Growth

- We continue our substantial progress in increasing sales and growing revenues without sacrificing margin. Herborium's revenue increased 18% in Q1 and 23% in Q2 in 2017, in comparison to the same periods of 2016.

- The Company's gross profit increased 20%, in Q1, 2017 and we expect the second Quarter to deliver similar results.

- We made a big push in international markets especially in France and UK where our sales doubled and we have open $1.4 trillion Hispanic market.

- We are pursuing number of new growth initiatives while capitalizing on diverse opportunities in the United States and overseas. Thanks to our global strategy we have been able to provide valuable solutions for all types of acne and other skin problems on almost EVERY continent.

New Products

In addition to taking advantage of $500 million dermatological market in North America and Europe, Herborium is committed to bring forward number of the new products to increase revenues and market penetration as well a to grow Herborium brand equity.

- Due to its unique differential advantage Herborium's Sexual Health product for women, "Lasting Pleasure" is on fast track for license and distribution agreements to take advantage of $1.5 billion natural sexual product market.

- Encouraged by the high level of interest in its Botanical Therapeutics Herborium expects to announce the commercialization plan to bring forward other proprietary all herbal, efficacious formulas addressing "hot" medical and wellness needs in the over $50 billion (combined) sexual performance, dermatology and most desired safe energy restoration markets. Specific announcements will follow.

Outlook for the remaining half of 2017

We look forward with confidence to a second half of 2017. The global nutraceutical market was valued at about $250 billion in 2016 and is expected to reach around $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth. Herborium is both excellently prepared and committed to take advantage of this opportunity.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 06/23/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health concerns including women sexual health, energy depletion and male sexual health, announced today that the first half of 2017 marks the highest semi-annual six sale in the Company's history with 21% growth in revenues comparing to the same 6 months period of 2016.

In addition to the sales growth In the first 6 months of 2017, the Company has also achieved other milestones -

- AcnEase US Facebook exceeded 75,000 likes and AcnEase France Facebook exceeded 60,000 likes

- The company entered $1.4 trillion US Hispanic Market

- The Company's blog was selected the Best Skincare Blog on the Internet the 3rd consecutive year (2015, 2016, 2017)- the distinction that significantly increases Herborium's and AcnEase brand equity and supports further increase in sales.

- Herborium launched strong efforts to monetize its organic women sexual product Lasting Pleasure through licensing and distribution partnerships, and was met with overnight high level interest form the potential partners and the public.

Outlook for the remaining half of 2017 is very optimistic.:

The global nutraceutical market was valued at about $250 billion in 2016 and is expected to reach around $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth. Herborium is in the excellent position to take advantage of this opportunity through adding new exciting products to its products portfolio, and through its efforts to increase market penetration in both retail and wholesale sectors. 

About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.www.acneasesp.com, www.acnease.co.uk.

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 06/21/2017 -- Herborium Group, Inc. (OTCMKTS:HBRM),  a Botanical Therapeutics Company and the provider of unique, all botanical medicines (Botanical Therapeutics®) announced today that due to the high level of interest in its Sexual Health product, "Lasting Pleasure" is on fast track for license and distribution agreements.  

Women's sexual health is a part of a $1.5 billion natural sexual product market and is quickly becoming an enormous opportunity as the topic becomes less taboo and is more openly discussed in popular media. In fact it is this exposure and increased popularity that has attracted many affiliates that have traditionally focused on male enhancement as they realize the sales opportunity that also exists in the female sexual enhancement market.

The only FDA approved drug to treat female sexual dissatisfaction or dysfunction, Addyi, has had little success in the market due to serious side effects. Developed by Sprout Pharmaceuticals and licensed to Valeant Addyi has performed very poorly owing to only a 10% better performance than placebo and its serious cardiovascular side effects including possibility of a stroke while taken with alcohol. Recent information from BioWorld Today suggests Addyi may be pulled from the market leaving Lasting Pleasure "as the only contender in this exponentially growing market. In contrast to Addyi, Lasting Pleasure can be administered with alcohol without any side effects, works immediately as well as long term and its initial confirmatory studies indicate over 85% customer satisfaction.

At some point in their lives, nearly all women experience low levels of sexual desire. The problem may result from hormonal fluctuations associated with pregnancy, childbearing, peri-menopause or menopausal change and also some medications, stress, exhaustion or environmental factors that can all contribute to sexual dysfunction and dissatisfaction.

Herborium Group has come a long way over the years and the time has now come to diversify and enter into a very strong sector of Organic Women Sexual Health, especially since Herborium's brand equity in women market has been very well established with AcnEase®, the Company's lead dermatological Botanical Therapeutic for acne that shows 15 consecutive quarters of sales growth. In addition, due to its unprecedented safety profile and convenience of use Lasting Pleasure can serve both therapeutic and recreational markets for sexual health products what significantly increases the interest of potential domestic and foreign partners.

About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, womens health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com,  www.acnease.fr and www.acneasesp.com.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Sunrise Consulting Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investorsrelations@herborium.com or DrAgnes@herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 06/08/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, announced today that initial review of the Second Quarter of 2017 shows 23% increase in Company's sales is in comparison to the same period of 2016.

The 23% increase in Herborium's revenue marks the 15th consecutive quarter of sales growth of the Company's proprietary, all herbal ingredients based acne treatment AcnEase and is attributed to successful execution of the specific aspects of Herborium Marketing Strategy.

Opening of Hispanic Market in March 2017.

$1.4 trillion Hispanic market is an ideal match for Herborium products and account for over 15% of the US e-commerce market. Hispanic purchasing power has increased at a compound annual growth rate of 7.5%, which is more than twice as fast as the 2.8% growth rate in the total U.S.

Increasing the wholesale distribution.

Increasing Amazon sales

Very successful Social Media Strategy.

AcnEase US Facebook exceeds now 85,000 likes and AcnEase France Facebook exceeds 75,000 likes. AcnEase Spanish Facebeook grew 5000% in first 6 weeks after it has been launched

AcnEase Blog has been ranked No 1 acne skincare blog on Internet the 3rd consecutive year (2015, 2016, 2017)

Outlook for the rest of 2017:

Herborium remains very optimistic about further growing its business, sales and product awareness in the US and abroad for the remaining half  of 2017.

The Company continues its efforts to increase market penetration in both retail and wholesale sectors.

The global nutraceutical market was valued at about $250 billion in 2016 and is expected to reach around $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth. Herborium is both excellently prepared and committed to take advantage of this opportunity.

About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products(FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.www.acneasesp.com, www.acnease.co.uk.

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 05/31/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicines (Botanical Therapeutics®) focused on unmet medical and wellness needs, announced today that its wholesale to HUT Group, LLC., the largest global e commerce retailer of wellness and beauty products increased  55% in the 5 months of 2017 in comparison to the same period of 2016. In addition, Herborium lead product AcnEase is designated to become a Brand of the Month on Hut Global e Commerce Platform that will further increase sale and strengthen the brand' global image.

Herborium sales to Hut AcnEase® (www.acnease.com, www.acnease.fr), its proprietary systemic, all herbal treatment for acne, oily skin and Rosacea that contains no chemicals and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts. AcnEase is considered a nutraceutical allowing Herborium to take advantage of the rapid global growth of the burgeoning nutraceutical market. The global nutraceutical market was valued at ~ USD 250 billion in 2016 and is expected to reach ~ USD 385 billion by 2021.

The HUT Group websites are Europe's fastest growing online lifestyle, health & and beauty destination. The Hut Group has also established a growing foothold in many other geographical regions and supports close to 200 million global website visitors, 100 million customers and over 10 million orders a year worldwide. Their Internet e commerce destinations include such on line stores as www.myprotein.com; www.LookFantastic.com; www.lookfanatsic.fr; www.beautyexpert.com, www.mankind.co.uk and number of their regional websites and on line stores.

About Herborium Group, Inc.
Herborium Group, Inc. is some botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products(FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com.

SOURCE: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 05/17/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, announced today that it signed a Distribution Agreement with Amazon Super-Seller, Golden Team Synergy of California to distribute Herborium's unique Botanical Therapeutic® for acne --AcnEase®.

AcnEase has been successfully sold on Amazon since 2010 and has achieved a significant increase in revenues, numerous orders and average value of the order. The increase in the average value of the order is especially significant since it indicates a growing consumer confidence in Herborium and its products. The average order value of AcnEase on Amazon increased 33% while the number of orders grew 113% since 2014.

The overall growth in revenues, increase in number of customers and the average order value for Amazon based sales has been a pivotal factor in Herborium' s decision to partner with Amazon Golden Team Synergy. Amazon Golden Team Synergy is one of the most prominent and successful Amazon Super-Seller with interest to  expending their natural wellness and beauty product base.

According to e-Marketer (August 2016) worldwide retail e commerce reached over 1.9 trillion dollars in 2016 and is expected to reach $4 Trillion in 2020. 2016 retail e commerce sales in North America rise 15.6% this year to reach $423.34 billion, maintaining the area's status as the world's second largest regional e commerce market after Asia. Amazon sales alone for 2016 reached impressive $136 million.

AcnEase provides a total solution for acne sufferers. The 100% botanical, proprietary treatment has a 96% user success rate, and is free of chemicals, hormones, preservatives, gluten, dairy, sugar and GMO's. While providing a uniquely, efficacious and safe product supported by clinical data, the brand is also focused on providing results-driven, life-changing content such as cutting edge educational information on acne, its treatment options, safety related issues, as well as tips for every day and special situation skincare

In April 2017 AcnEase® skincare treatment blog (www.acnease.com/acne-treatment-blog/) has been named, the Best Skincare Blog of 2017 by the distinguished Healthline.com. The AcnEase blog was selected by Healthline to join the exclusive list of winners for the 3rd year in a row (2015, 2016 and 2017) and praised as one of "the most up-to-date, informative, and inspiring blogs that aim to uplift their readers through education and personal stories".

www.healthline.com/health/best-skin-care-blogs.

There are over 60 million people in the US alone who suffer from acne and who need real help and support. Over 75% of all individuals will have acne at a certain period of their life, and the average age of an acne sufferer today is 26.5, which negates the myth that acne is a teen problem that goes away on its own.

The new distribution arrangements and partnership with Amazon Super Seller distinguished for its successful and ethical business practices is another example of Herborium's aggressive Road-To-Market with the ultimate and ambitious goal to eventually capture 1% of the Global Natural Treatments and Beauty Market.

About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products(FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.www.acneasesp.com, www.acnease.co.uk.

Safe Harbor Statement: 
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed.  The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 05/09/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique, all botanical medicines (Botanical Therapeutics®) announced today that sales of AcnEase®, the Company's proprietary all botanical acne treatment, in French market increased 50% in comparison to 2016. The gross margin increased from 63.5% to 66.5% and the value of single order increase by over 18%.

France is the 4th largest market in the world ($7 billion). Its beauty market is the second largest in the world surpassed only by the US market. Skin care is the main beauty expense growing exponentially in France with 33% of the market.

France is also a very strong participant in over $3 trillion global wellness markets.

86% of French consumers use at least one natural personal care, nutritional or natural cosmetic product. This trend is even more prevailing among women (93%) and the 18-24 years old (91%) that represent the largest acne affected market segments in France. Over 25% of French, 65 million in population (not including overseas territories), are affected by acne. The natural cosmetics market in France has increased by approximately 20% every year since 2005 and had reached over €600 million in 2016.

As a part of its global strategy and to realize the opportunity afforded by AcnEase special status as both beauty and wellness product Herborium launched a wholly designated French website www.acnease.fr in 2014.

AcnEase® Social Media Strategy in France has been very successful and grew 500% in 2016 compared to 2015. AcnEase French Facebook following has over 70,000 featured by top bloggers while its YouTube personalities in France accumulated over 5 million followers. AcnEase supporters in France include, among others: Coline (et pourqois Coline), EnjoyPhoenix, one of the biggest Youtuber in France featured on French TV and in the legendary Elle Magazine, Sweet Honey Bee: a leading blogger focusing on young women with acne and Sandrea 26 France, one of the most prominent influencers in France. With 1 million subscribers on Youtube, 37,000 fans on Facebook and 1 million followers on Instagram.

During the past year AcnEae has also won a recognition of a more traditional media in France and had been featured in Cosmopolitan Magazine in May of 2016 and in January 2017 side by side with Lancome products as a top pick of the month, and as one of the most innovative and recommended products for acne.Cosmopolitan Magazine is one of the best-selling women's magazines (average women's age 34) in France and reaches more than 3,300,000 readers each month in this country alone.

AcnEase e-commerce success that Herborium continue to further also provides an excellent foundation for the next step in French market penetration that is wholesale and retail market. In 2017 Herborium focuses on establishing the relationship with such leading retailers in France as Parashop, the leader in "parapharmacie" on the French market with 69 stores in France, 4 in Italy and 2016 sales of over 135 million Euro and Giphar (Groupement Independant de PHARrmaciens independants). The aforementioned efforts will allow to grow French sales by double digits again in 2017.

About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, and www.acnease.fr.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Sunrise Consulting Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 04/24/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, is proud to announce today that AcnEase®, the Company's unique all herbal, clinically tested acne treatment (www.acnease.com) has been featured on LIVNGLY as a "herbal miracle worker" for acne, blackheads and whiteheads. LIVINGLY is a flagship lifestyle website owned by Livingly Media, and part of one of the largest diversified media companies in the world, Axel Springer.

LIVINGLY has been acquired by one of Axel Springer subsidiaries, aufeminin, a top publisher of women's websites worldwide. Their editorial and community-based properties in the categories of parenting, food, health, fashion and beauty, and women's lifestyle reach an audience of over 100 million unique visitors.

There are over 60 million people in the US alone who suffer from acne. Over 75% of all individuals will have acne at the certain period of their life, and the average age of an acne sufferer today is 26.5, which negates the myth that acne is a teen problem that goes away on its own. Many presently used acne treatments pose variety of health concerns. This includes Accutane, a subject of Class Action Suite for its severe adverse effects, antibiotics and off label use of oral contraceptives, as well as number of topical agents.

AcnEase® is 100% botanical, proprietary treatment for acne with 96% user success rate and an unprecedented safety profile. AcnEase is free of chemicals, hormones, preservatives, gluten, dairy, sugar and GMO's.

Named a top beauty pick by Cosmopolitan France in May 2016, AcnEase provides not only a breakthrough treatment for different types of acne but also award winning content (AcnEase Blog is a Winner of the Best Skincare Blog by Healthline for 3 consecutive years) focused on results-driven, life-changing information such as cutting edge educational data on acne, its treatment options, safety related issues, social impact of acne,  and tips on coping with every day and special situation skincare problems.

About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.www.acneasesp.com, www.acnease.co.uk.

Safe Harbor Statement: 
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com or DrAgnes@Herborium.com

Source: UPTICK Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 04/20/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, is proud to announce today that the AcnEase® skincare treatment blog (www.acnease.com/acne-treatment-blog/) has been named, the Best Skincare Blog of 2017 by the distinguished Healthline.com.  The AcnEase blog was selected by Healthline to join the exclusive list of winners for "the most up-to-date, informative, and inspiring blogs that aim to uplift their readers through education and personal stories". www.healthline.com/health/best-skin-care-blogs. This is the third consecutive year when AcnEase blog is a recipient of this distinctive award. (2015, 2016 and 2017)

AcnEase provides a total solution for acne sufferers. The 100% botanical, proprietary treatment has a 96% user success rate, and is free of any chemicals, hormones, preservatives, gluten, dairy, sugar and GMO's. While providing a uniquely efficacious and safe product, the brand is also focused on providing results-driven, life-changing content such as cutting edge educational information on acne, its treatment options, safety related issues, as well as tips for every day and special situation skincare. The AcnEase Total Acne Solution was specifically developed to help to not only eradicate acne but also to provide a support system against psychological effects often associated with this skin disease. AcnEase mission also includes developing awareness about safety concerns associated with some products used to treat acne, and about serious short and long-term personal and social issues associated with having acne.

There are over 60 million people in the US alone who suffer from acne and who need real help and support. Over 75% of all individuals will have acne at the certain period of their life, and the average age of an acne sufferer today is 26.5, which negates the myth that acne is a teen problem that goes away on its own.

Named a top beauty pick by Cosmopolitan France in May 2016 , AcnEase is not only a treatment against acne, it is also voice for people with acne. Unfortunately, kids as young as 9 years old are affected by acne, and so are individuals over 40 years old. Acne does not know economic, gender or ethnic boarders.

Herborium through its AcnEase-Total Acne Solution is dedicated to provide breakthrough treatment option for acne sufferers and to creating a disruptive innovation that establishes a new market and value network for natural science based skincare.

Herborium plans introducing the product extension for AcnEase treatment line in 2017

About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.www.acneasesp.com, www.acnease.co.uk.

Safe Harbor Statement: 
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 04/18/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, announced today that its First Quarter of 2017 is marked by two-digit growth of the Company's Revenues and Gross Profit in comparison to the same period of 2016.

The Achievements of the Q1, 2017:

- Herborium's revenue increased 18% in comparison to Q1, 2016, to approximately $223,000 in sales.

- The Company's gross profit increased 20%, over Q1, 2016, to $135,500 in 2017.

- Operating income loss was decreased 80% in comparison to operating income loss in Q1, 2016

- The Gross margin remained unchanged at the healthy 65%

- AcnEase US Facebook exceeded 75,000 likes and AcnEase France Facebook exceeded 55,000 likes

- In the First Quarter of 2017 the company built the high quality Spanish Website and Social Media platform for AcnEase to prepare monetization of the $1.4 trillion US Hispanic Market opportunity

The above milestones are an integral part of the Company's growth strategy and its efforts to increase shareholders value. In addition to the above, the First Quarter of 2017 also brought the following important brand and sales building accomplishments:

- The Company established relationship with a number of top new influencers in USA, France, Canada, Spain and Argentina to increase global brand visibility.

- The Company initiated number of efforts to increase wholesale distribution of AcnEase that becomes one of the focal point of marketing effort in 2017.

- The Company is pursuing the number of venues to monetize its sexual Botanical Therapeutics.

- The Company identified and secured the product extension and products line extension opportunities for AcnEase Skin Management System planned to be introduced in 2017.

Outlook for 2017:

Herborium remains very optimistic about growing its business, sales and product awareness in the US and abroad.,

The Company continues its efforts to increase market penetration in both retail and wholesale sectors with the latest becoming a priority in 2017.

The Company also continues to decrease costs and retire debt. While the Company is still recognizing the expenses associated with developing new markets and preparing the launch of new products Herborium continues its growth, its search for partners and creative financing opportunities to support this growth.

The global nutraceutical market was valued at about $250 billion in 2016 and is expected to reach around $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth. Herborium is both excellently prepared and committed to take advantage of this opportunity.

About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.Herborium.com, www.acnease.com, www.acnease.fr.www.acneasesp.com, www.acnease.co.uk.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com

Source: UPTICK Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 03/23/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne and other health and wellness concerns, announced today that the Company's most established brand AcnEase®, a Botanical Therapeutic® for acne, has been launched in the $1.4 trillion US Hispanic Market.

The Hispanic market is both e-commerce savvy and personal care conscious. Educational and cultural gains made the market a very prominent part of the US and world economy, accounting for over 15% of the US e-commerce market. AcnEase is the ideal product for a market that appreciates natural products.

Hispanic purchasing power has increased at a compound annual growth rate of 7.5%, which is more than twice as fast as the 2.8% growth rate in the total U.S.

The response of the new market to AcnEase is both immediate and very strong. The newly open Spanish language website, www.acnesesp.com, and Herborium launched a Spanish language Social Media strategy and gained the immediate attention of the global Spanish language market. Orders are pouring in from Mexico, Argentina and Spain, and two major Spanish language influencers, Amanda Chic and Nury, have joined the campaign.

Herborium expects to triple its Hispanic Market outreach in 2017. This will have a strong impact on boosting the Company revenues, introducing new products and profitability, as well as accelerating the Company's ability to reach other strategic goals.

On Uptick Newswire's Stock Day Podcast, https://upticknewswire.com/ceo-dr-agnes-olszewski-herborium-group-talks-sales-focus-2017/, Herborium CEO Dr. Agnes P. Olszewski confirmed the Company's commitment to up-list and to work towards increasing shareholder value.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorRelations@Herborium.com or DrAgnes@Herborium.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 03/01/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, is proud to announce that Herborium finished 2016 as the first positive cash flow year. As indicated in our Annual Report for 2016, this year has been rich in important developments and represents a pivotal milestone for the Company's growth.

- Herborium's revenue increased by 18.3 % (by approximately $130,000) to approximately $843,000 in sales in comparison to 2015.

- The Company's gross profit increased by 16.3%, approximately $75,000 over 2015, to $530,000 in 2016.

- Operating income loss was eliminated and the Company went from a loss in 2015 to slight profit in 2016.

- The Company net loss for 2016 decreased by 40%, from $87,000 in 2015 to $54,000 in 2016.

- The Company's Acne blog was ranked on "The Best Skincare Blogs of 2016" by Healthline for the SECOND CONSECUTIVE YEAR.

- AcnEase Facebook reached close to 67,000 likes.

- AcnEase was featured TWICE as a unique acne treatment and beauty pick in Cosmopolitan Magazine in France.

Outlook for 2017:

- Herborium remains very optimistic about growing its business, sales and product awareness due to the steady growth of the AcnEase® brand in the US and abroad, as well as new products to enter the market in 2017.

- The Company continues its efforts to increase market penetration in both retail and wholesale sectors with the latest becoming a priority in 2017.

- The Company also continues to decrease costs and retire debt. While the Company is still recognizing the expenses associated with developing and preparing the launch of new products, 2016 was the first year for positive cash flow for Herborium.

- Herborium will continue its growth and its search for partners and creative financing opportunities to support this growth. The global nutraceutical market was valued at about USD $250 billion in 2016 and is expected to reach around USD $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of the growth.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.

Safe Harbor Statement
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed.  The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com or DrAgnes@Herborium.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 02/23/2017 -- Herborium® Group, Inc. (OTCPink:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, is proud to announce that AcnEase®, Herborium' s signature Botanical Therapeutic® for acne, has been featured for the second time in the past 10 months in the top women's magazine in the world, Cosmopolitan, as one of the most innovative acne treatments. The first time AcnEase was featured in Cosmopolitan was in May 2016 when it appeared side by side with Lancome products as a top pick of the month. In the January/February 2017 issue, AcnEase made its way into the editorial on acne care as one of the most innovative and recommended products for acne.

Cosmopolitan Magazine is one of the best-selling women's magazines (average women's age 34.4) in France and reaches more than 3,300,000 readers each month in this country alone, and 78,000,000 readers in the world. Twenty-five percent of the magazine readers are young men (average age 28.5 years old) that account for a very loyal readership group. Cosmopolitan magazine was established in the USA in 1886 by Hearst and now has 57 editions all around the world.

Over 80 million people have acne in the USA alone. Seventy five percent of all individuals will suffer from acne at some point in their lives. The acne treatment and prevention market is growing while at the same time, no new products are emerging and the number of previously used treatments is dwindling or restricted because of recognized health concerns (examples: Accutane, antibiotics, oral contraceptives).

AcnEase® is a systemic, proprietary all herbal product that contains no chemicals and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts with no adverse side effects. During the last decade, the average age of an acne sufferer increased from 21 to 26 years old, making adult acne an epidemic. At the same time, a number of standard treatments for acne such as antibiotics or oral contraceptives have been raising serious health concerns from both medical, professional and consumers and are subject to several new restrictions and/or restrictive guidelines.

From a regulatory perspective, AcnEase is considered a nutraceutical allowing it to take advantage of the rapid global growth of the nutraceutical market. For instance, the global nutraceutical market is valued at around 250 billion USD in 2016 and is expected to reach around 385 billion USD by 2021, at a CAGR of 7.5% from 2016 to 2021. The US nutraceutical market has dominated this growth accounting for ~ 36% of this growth.

"AcnEase's appearance in Cosmopolitan's first issue of 2017 is a strong reaffirmation for our brand strategy and a unique value represented by our product. The fact that AcnEase has been featured by Cosmopolitan magazine for the second time during the past 10 months is a clear testimonial to our strong position and recognition in the French marketplace, which is the second largest beauty market in the world. Combining these meaningful events with the rising interest in Botanical Therapeutics® among consumers and medical professionals in the USA and around the world, this affirmation serves as a solid foundation for the company's future successful expansion," commented Dr. Agnes P. Olszewski, Herborium CEO and Charwomen.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com or DrAgnes@Herborium.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 01/30/2017 -- Herborium® Group, Inc. (OTCPink:HBRM), a Botanical Therapeutics® Company providing unique, all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne as well as other health and wellness concerns, announced today that its CEO, Dr. Agnes P. Olszewski, was interviewed by Prominent Wealth & Finance International.

The full interview can be read at http://www.wealthandfinance-intl.com/wealth---finance-january-2017 and http://www.wealthandfinance-intl.com/

Wealth & Finance International is highly recognized publication targeting an established global network of high net worth individuals, forward-thinking fund managers and private and institutional investors, hungry for the latest news and opinion on the issues that matter most.

With a global audience of over 130,000, our engaged and established readership stretches from North America (51%) and Europe and UK (38%) to Asia and the Middle East. In addition Wealth and Finance is also available on ISSUU platform with over 100 Million Unique Visitors per month.

Dr. Agnes talked about the new landscape of the nutraceutical market and the opportunities and challenges of natural medicine and wellness. She points out how Herborium's proprietary Botanical Therapeutics®, its innovative business model and its unique blend of expertise has positioned the company in the bull's eye of this aggressively growing sector.

The global nutraceutical market is currently valued at about USD $250 billion in 2016 and is expected to reach ~ USD $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth.

Herborium's sales results for the first three quarters of 2016 grew by 14% in comparison to the same period of 2015, and the fourth quarter results beat expectations and grew 16.8% in comparison to the same period of 2015

Herborium's Botanical Therapeutics are systemic, proprietary, all herbal products that contain no chemicals, gluten, or GMOs and have been scientifically validated with respect to their efficacy and safety. They address unsatisfied market needs such as Acne and Rosacea ($5 billion), Male Sexual Health ($8 billion), Women's Sexual Health ($6 billion) and energy restoration ($9 billion)

Wealth and Finance encourages contribution from some of the most prominent and respected figures from the funds and investment arenas, Wealth & Finance is also an important forum for sharing, discussing and gaining a holistic and in-depth understanding of the issues and challenges shaping the industry today.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's sexual health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com.

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 01/17/2017 -- Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne, and other health and wellness concerns is happy to announce that as of Tuesday, January 10, 2017 the Company has achieved OTC Pink Current information status, which implies that the company is providing adequate current information pursuant to the OTC Markets Guidelines for Pink companies.

This development reflects the Company's on-going commitment to create and increase shareholders value while fostering the Company growth and development. The global nutraceutical market was valued at ~ USD 250 billion in 2016 and is expected to reach ~ USD 385 billion by 2021.

Herborium Group's products and expertise in developing and marketing proprietary, all herbal medicinal formulas (Botanical Therapeutics®) with a proven record of efficacy, represents an ideal fit with new, nutraceutical market trends, as well as more demanding manufacturing and regulatory standards for the industry.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:

Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 01/12/2017 -- Herborium® Group, Inc. (OTCPink:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne, and other health and wellness concerns is happy to announce that as of Tuesday, January 10, 2017 the Company has met all requirements of the Company with OTC Current Status and has been placed on the highest OTC tier.

This development reflects the Company's on-going commitment to create and increase shareholders value while fostering the Company growth and development. The global nutraceutical market was valued at ~ USD 250 billion in 2016 and is expected to reach ~ USD 385 billion by 2021.

Herborium Group's products and expertise in developing and marketing proprietary, all herbal medicinal formulas (Botanical Therapeutics®) with a proven record of efficacy, represents an ideal fit with new, nutraceutical market trends, as well as more demanding manufacturing  and regulatory standards for the industry.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics®  company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations @Herborium.com  or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 01/05/2017 -- Herborium® Group, Inc. (OTCPink:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and rosacea, and other health and wellness concerns, is happy to provide this Shareholders Update Letter from Dr. Agnes P. Olszewski the CEO.

To Our Valued Shareholders,

Happy New Year!

By now the last pie has been eaten and the last gift unpacked so it's time to provide an update on the recent milestones we achieved in 2016 and discuss our opportunities and our vision for 2017 and the Company's future.

As the first step we would like to highlight several recent business activities since the last year was full of milestones for Herborium Group.

We achieved substantial progress implementing strategies to increase sales, strengthen our brand recognition and reactivate efforts to create and capture shareholders value. Every quarter in 2017 our sales grew by double digits. Pivotal sales events including Black Friday and Cyber Monday showed sales of our leading product, AcnEase®, increased 105% over the same sales events in 2015.

Revenues & Sales Growth

We are pursuing number of growth initiatives while capitalizing on diverse opportunities in the United States and overseas. Thanks to our global strategy we have been able to provide viable solutions for all types of acne and other growing skin problems on almost EVERY continent. From Europe to the Caribbean's, from the skyscrapers of New York to bustling towns of Asia, from historical South America to the colorful cities of Africa our unique acne treatment AcnEase® has helped thousands of women and men of every age and skin tone achieve healthy skin, and a healthy self–perception. This global outreach resulted in 18% sales growth in comparison to the previous year. We have accomplished this without sacrificing our healthy margin.

Over 75 million people have acne in the USA alone;120 million I Europe. Seventy five percent of all individuals will suffer from acne at some point in their lives. The acne treatment and prevention market is steadily growing while at the same time no new products are emerging and the number of previously used treatments is dwindling or restricted because of recognized health concerns (Accutane, antibiotics, oral contraceptives as examples). The average age of the acne sufferer has increased during the past decade from 21 years old to 26 years old, making adult acne an burgeoning epidemic.

AcnEase® is a systemic, proprietary all herbal product that contains no chemicals, no gluten, animal by products or phytoestrogens and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts with no adverse side effects. From a regulatory perspective, AcnEase is considered a nutraceutical allowing AcnEase to take advantage of the rapid global growth of the nutraceutical market. For instance, the global nutraceutical market is valued at around USD 250 billion in 2016 and is expected to reach around USD 385 billion by 2021, at a CAGR of 7.5% from 2016 to 2021. The US nutraceutical market has dominated this growth accounting for ~ 36% of this growth.

We made a big push in international markets in 2016 especially in France and UK where our sales doubled. We developed new, promising distribution partnerships in these markets and revitalized old once. We expect this strengthen distribution infrastructure to support further sales growth in 2017.

New Mobile Websites and Social Media Presence

6 months ago we deployed new, state of the art mobile websites for English, French and Spanish markets and expect these platforms to support further sales growth. Deployment of the Spanish language website and formulation of the Spanish language market strategy has been especially important as Hispanic beauty and wellness market is the FASTEST growing sector in the USA and globally with 97% of Hispanic households are buying products in this category with 8% growth in spending annually. By the end of 2016 we have established relationships with two powerful social medial influencers in the Spanish market and we expect this market to become a strong driver for our 2017 revenues.

In 2016 we made a real splash in media both in the USA and abroad. We were chosen by Cosmopolitan Magazine (one of the most prominent women's publication in the world) as a top beauty editor pick for  acne treatment; we won the Top Acne and Skincare Blog by Healthline for the second year in a row; AcnEase has been featured on ABC and CBS TV shows in such important geodemographically areas as the San Francisco Bay Area and Seattle, AcnEase has also been picked up by a number of prominent influencers with hundreds of thousands of followers in the US and overseas.

New Opportunities

Last but not least, it is important to note that in 2016 the Company developed a strategy for product line extension in skincare sector and for commercializing its unique Botanical Therapeutics® in the highly demanded sectors of women and men's sexual health and energy replenishment. In 2017 Herborium will focus on adding a complementary skincare product to AcnEase line and on pursuing licensing and direct commercial opportunities for the sexual health and energy formulations that combined represent over $50 billion market potential.

Capital Structure

All 2016 milestones and progress have been achieved without increasing the number of outstanding shares and without any changes in the Company's capital structure.

In summary, 2016 marked a significant progress and established a solid foundation for the future growth of the Company and increase in shareholders value.

We are looking forward with confidence to a great 2017 and we are committed to share all the important developments with our shareholders. With a growing global demand for natural wellness and beauty products, and natural medicinal products Herborium's unique Botanical Therapeutics® provide both an opportunity for the Company and a valuable solution for global challenges and evolving consumer and healthcare sector needs. With the growing demand for its signature acne product, new products ready for commercialization and a near term pipeline supported by o its unique expertise, Herborium Group is in an ideal position to take advantage of emerging nutraceutical market trends and to meet more demanding consumer, manufacturing and regulatory standards for the industry.

Sincerely,

Dr. Agnes P. Olszewski CEO & Chairwoman

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com  or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 12/20/2016 -- Herborium® Group, Inc. (OTCPINK:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, is proud to announce that AcnEase®, Herborium' s signature Botanical Therapeutic® for acne has been featured on Good Day Sacramento, the top-rated morning program in Sacramento - San Francisco area as a "holiday sanity survival product". AcnEase was presented on a beauty segment during the 9am hour PST on Sunday, 12/18 2016.

http://gooddaysacramento.cbslocal.com/show/latest-video/video-3595136-beauty-expert-stacy-cox/

Good Day Sacramento (KPIX-TV/CBS 5) reaches tens of millions of affluent households from Sacramento to the Bay Area with 60MM monthly unique visitors and 36MM monthly mobile unique visitors. Over 1 in 3 users have a salary of $100,000 or higher.

Stacy Cox, the beauty correspondent who presented AcnEase, is a 15-year broadcast veteran who works on KTLA in LA, Fox 5 in NY, Dr. Oz, The View, E!, Access Hollywood and many more and she is also a nationally recognized licensed esthetician expert.

Stacy discusses AcnEase and says, "I've been an esthetician 6 days a week for 17 years since January of 1999.  This is the first natural option to heal and minimize the appearance of acne with NO side effects that I've come across.  This is both ground breaking and revolutionary in my eyes and from my aesthetic perspective, can dramatically change people's lives for the better both physically and emotionally."

Over 80 million people have acne in the USA alone. Seventy five percent of all individuals will suffer from acne at some point of their lives.  The acne treatment and prevention market is growing while at the same time no new products are emerging and the number of previously used treatments is dwindling or restricted because of recognized health concerns. (Accutane, antibiotics, oral contraceptives as examples) The average age of the acne sufferer has increased during the past

AcnEase® is a systemic, proprietary all herbal product that contains no chemicals and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts with no adverse side effects. During the last decade, the average age of acne sufferer increase from 21 years old to 26 years old, making adult acne an epidemic. At the same time number of standard treatments for acne such as antibiotics or oral contraceptives has been raising serious health concerns from both medical professional and consumers and are subject several new restrictions and/or restrictive guidelines.

From a regulatory perspective, AcnEase is considered a nutraceutical allowing AcnEase to take advantage of the rapid global growth of the nutraceutical market.  For instance, the global nutraceutical market is valued at around USD 250 billion in 2016 and is expected to reach around USD 385 billion by 2021, at a CAGR of 7.5% from 2016 to 2021. US nutraceutical market has dominated this growth accounting for ~ 36% of this growth.

"This TV event represents an excellent year-ending for Herborium and AcnEase reconfirming our optimism about Herborium results in 2016, solidifying our expectations for the further dynamic growth in 2017. The rising interest in Botanical Therapeutics® among consumers and medical professionals in the USA and around the world, serve as a solid foundation for the company's future successful expansion" commented Dr. Agnes P. Olszewski, Herborium CEO and Charwomen.

About Herborium Group, Inc.
Herborium Group, Inc. is some botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, http://www.acnease.fr

Safe Harbor Statement: 
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: Investors Relations @Herborium.com or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 12/13/2016 -- Herborium® Group, Inc. (OTCPink:HBRM), a Botanical Therapeutics® Company providing unique, all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne as well as other health and wellness concerns, announced today that a radio interview with its CEO, Dr. Agnes P. Olszewski, is available on a number of public venues including:

UPTICK Newswire Radio - https://upticknewswire.com/dr-agnes-olszewski-ceo-of-herborium-group-talks-about-their-signature-botanical-treatment-for-acne/

Investors Hangout: https://investorshangout.com

Google Play: https://play.google.com/music/m/Dtpzvif6zs2t4fdsuat2odamiiu?t=Dr_Agnes_Olszewski_CEO_of_Herborium_Group_talks_About_their_Signature_Botanical_Treatment_for_Acne-U

iTunes - https://itunes.apple.com/us/podcast/uptick-network/id1076183234?mt=2&ign-mpt=uo%3D4#

iHeartRADIO: http://www.iheart.com/show/53-Uptick-Network/

Audio Boom!: https://audioboom.com/posts/5374060-dr-agnes-olszewski-ceo-of-herborium-group-talks-about-their-signature-botanical-treatment-for-acne

Dr. Agnes talks about the Company's two-digit growth over the last eight quarters, the unprecedented 105% increase in sales for 2016 Cyber Monday and Black Friday, and the global opportunities for Herborium's unique Botanical Therapeutics®.

The global nutraceutical market is valued at about USD $250 billion in 2016 and is expected to reach around USD $385 billion by the year 2021. The United States nutraceutical market has dominated this growth, accounting for approximately 36% of this growth.

Dr Agnes also discusses a differential advantage of Herborium's signature product for acne, AcnEase®, and the Company's other Botanical Therapeutics® offering insight to the Company's strategy for continuous growth in 2017.

Recent sales results continue to surpass Herborium's 2015 performance and the Company expects record results in 2016. (The combined sales for the first three quarters of 2016 grew by 14% in comparison to the same period of 2015).

Over 75 million people suffer from acne in the USA alone, with an additional120 million sufferers, from this reoccurring problem, in Europe. Seventy five percent of all individuals will suffer from acne at some point in their lives. The average age of the acne sufferer has increased during the past decade from 21 years old to 26 years old, making adult acne an epidemic.

AcnEase® is a systemic, proprietary all herbal product that contains no chemicals and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts with no adverse side effects.

The acne treatment and prevention market is growing while at the same time no new medical products are emerging and the number of previously used treatment options is decreasing or are restricted due to recognized health concerns. (i.e. Accutane, antibiotics, oral contraceptives)

With the growing need for its signature product, new products in the pipeline and its unique expertise, Herborium Group is in an ideal position to take advantage of emerging nutraceutical market trends and to meet more demanding manufacturing and regulatory standards for the industry.

About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's sexual health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com.

Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com
Website: http://www.herborium.com
Phone: 201-849-4431

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Fort Lee, NJ -- (ReleaseWire) -- 12/08/2016 -- Herborium® Group, Inc. (OTCPink:HBRM), http://www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicines (Botanical Therapeutics®) focused on unmet medical and wellness needs, announced today that the sale of Herborium's lead product AcnEase® to HUT Group, LLC., the largest global e commerce retailer of wellness and beauty products, doubled in 2016 in comparison to 2015.

AcnEase® www.acnease.com, www.acnease.fr, is a systemic, proprietary, all herbal product that contains no chemicals and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts. In addition, AcnEase has not been associated with any adverse side effects for short term and long term use. From a regulatory perspective, AcnEase is considered a nutraceutical allowing Herborium to take advantage of the rapid global growth of the nutraceutical market.

The burgeoning nutraceutical and wellness market derives its strength from consumer's view of nutritional products being the key to managing health, and the growing trend to focus on prevention instead of reaction to health issues. The global nutraceutical market was valued at ~ USD 250 billion in 2016 and is expected to reach ~ USD 385 billion by 2021.

Herborium Group's products and expertise in developing proprietary, all herbal medicinal formulas (Botanical Therapeutics®) with a proven record of efficacy, represents an ideal fit with new, nutraceutical market trends, as well as more demanding CGMP manufacturing standards for the industry.

The HUT Group websites are Europe's fastest growing online lifestyle, health & and beauty destination. The Hut Group has also established a growing foothold in many other geographical regions and supports close to 200 million global website visitors, ~10 million customers and over 10 million orders worldwide. Their Internet e commerce destinations include such on line stores as www.myprotein.com; www.LookFantastic.com; www.lookfanatsic.fr; www.beautyexpert.com, www.mankind.co.uk and number of other regional websites and on line stores.

"We are very excited about the present sales growth of AcnEase® on HUT's unique "end to end" technology platform. With potential for a million page views daily our Botanical Therapeutics® will reach millions of customers in Europe and Asia. Together with Hut's marketing experts we are working on making AcnEase a "£1,000,000 baby" on the HUT platform." commented Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium.

About Herborium Group, Inc.
Herborium Group, Inc. is some botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com

Source: Uptick Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm